NCT06856798View on ClinicalTrials.gov

Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: a Multi - Omics Perspective

Not yet recruitingOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

March 9, 2026

Study Completion Date

February 9, 2028

Conditions

NSCLC Stage IIIA/BNSCLC Stage II

All Listed Sponsors

lead

Ziming Li

OTHER